Sponsor or institution
Clinical trials and research at Replimune, Inc.
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Replimune, Inc. that are recruiting, at sites in 8 countries (most in United States (4), United Kingdom (2), Australia (2)). By phase: Phase 3 (1), Phase 2 (1), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 8Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Long-term safety follow-up after RP1, RP2, or RP3 treatment | — | La Jolla, California and 1 other locations | Recruiting | Mar 20, 2025 |
| Investigating RP2 and Nivolumab for Metastatic Uveal Melanoma | Phase 2/3 | Scottsdale, Arizona and 32 other locations | Recruiting | Sep 3, 2024 |
| Comparing VO and Nivolumab to Standard Treatment for Advanced Melanoma | Phase 3 | Gilbert, Arizona and 80 other locations | Recruiting | Feb 16, 2024 |
| Evaluating RP2 with second-line therapy for advanced liver cancer | Phase 2 | Beverly Hills, California and 11 other locations | Recruiting | Feb 17, 2023 |
All recruiting trials (4)
-
Long-term safety follow-up after RP1, RP2, or RP3 treatment
This study will follow people with melanoma or other advanced solid tumors who previously received RP1, RP2, or RP3 to see if any delayed side effects appear over five years.
-
Investigating RP2 and Nivolumab for Metastatic Uveal Melanoma
This study is testing whether a new treatment combining RP2 with nivolumab can help adults with metastatic uveal melanoma feel better compared to the standard treatment of nivolumab and ipilimumab.
-
Comparing VO and Nivolumab to Standard Treatment for Advanced Melanoma
This study is testing if a new combination of treatments, Vusolimogene Oderparepvec and nivolumab, can help people with advanced melanoma who haven't responded to other therapies feel better compared to standard treatments.
-
Evaluating RP2 with second-line therapy for advanced liver cancer
This study is testing if a new treatment called RP2, used with two other medications, can help people with advanced liver cancer who haven't responded well to previous treatments.
Quick answers
How many clinical trials run by Replimune, Inc. are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in United States (4 trials), United Kingdom (2 trials), Australia (2 trials), France (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.